Maximize Conference Impact Virtually – Engaging Your Advisors Creatively
July 10, 2025 |
Extend the impact of scientific conferences! Discover how to creatively empower your advisors to share patient cases and evidence, sparking rich discussions on clinical implications and research questions. Drive deeper engagement post-congress!
Transform your post-conference engagement and extend the life of valuable insights. Explore innovative ways to leverage virtual platforms for congress coverage and post-conference engagement initiatives. Empower your advisors to share patient cases, digest emerging evidence from sessions, and spark deep discussions on data significance, clinical implications, and unanswered research questions. Learn how to foster ownership and generate rich, ongoing dialogue long after the live event concludes.
- Congress Coverage and Post-Conference Engagement Initiatives
- Enable advisors to submit patient cases or evidence digests from live conferences.
- Facilitate thought-provoking discussions on data, clinical implications, and research questions.
- Empower advisors to moderate their own questions, fostering ownership and deeper engagement.
- Extend the impact of conference sessions through sustained virtual dialogue.
For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/
Learn more about Impetus Digital’s solutions: www.impetusdigital.com
Schedule a consultation: https://meetwithimpetus.com/
Stay connected:
- LinkedIn: https://linkedin.com/company/impetus-digital
- Twitter: https://twitter.com/impetus_digital
- Facebook: https://facebook.com/ImpetusDigital.fb
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Repurposing Off-Patent Drugs Through Crowd Funding
Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies.
Virtual Tools for Promoting Diversity in Pharma and Clinical Trials
It is no secret that Pharma (still) has a major diversity problem.
How to Increase Engagement During Virtual Events
Tip #7 – How do you increase engagement during virtual events? Make it fun! ️ See all Top 10 tips: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/
How to Increase Engagement During Virtual Events
Tip #6 – Individualizing a virtual event for your participants makes it more likely for them to attend and gain something valuable from the event. Learn how else you can…
How to Increase Engagement During Virtual Events
Tip #5 – Do you want to increase engagement during virtual events? To allow deep-dives into new data, discuss gaps/needs, or brainstorm new ideas, moderated small-group breakout sessions and workshops…
How to Increase Engagement During Virtual Events
Tip #4 – How do you plan the agenda for your virtual event? We suggest to invite participant input to build and personalize the engagement. Check out our full top…
How to Increase Engagement During Virtual Events
Tip #3 – Keep it simple! Check our top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) face-to-face again, believing that’s what most KOLs want. It may…
How to Increase Engagement During Virtual Events
Tip #2 – Are you team “”jump on a call”” or team “”just email me””? Instead of choosing just one, try using a combination of synchronous (real-time) and asynchronous (over-time,…
How the Legally Blind Can Achieve Enhanced Vision
Roland Mattern, Director of Product Marketing at eSight Eyewear, shares how eSight’s technologies are being used to bring sight back to people living with central vision loss. He also discusses…